Developmental toxicity of prenatal exposure to toluene

Journal Title: The AAPS Journal - Year 2006, Vol 8, Issue 2

Abstract

Organic solvents have become ubiquitous in our environment and are essential for industry. Many women of reproductive age are incresingly exposed to solvents such as toluene in occupational settings (ie, long-term, lowconcentration exposures) or through inhalant abuse (eg, episodic, binge exposures to high concentrations). The risk for teratogenic outcome is much less with low to moderate occupational solvent exposure compared with the greater potential for adverse pregnancy outcomes, developmental delays, and neurobehavioral problems in children born to women exposed to high concentrations of abused organic solvents such as toluene, 1,1,1-trichloroethane, xylenes, and nitrous oxide. Yet the teratogenic effects of abuse patterns of exposure to toluene and other inhalants remain understudied. We briefly review how animal models can aid, substantially in clarifying the developmental risk of exposure to solvents for adverse biobehavioral outcomes following abuse patterns of use and in the absence of associated health problems and co-drug abuse (eg, alcohol). Our studies also begin to establish the importance of dose (concentration) and critical perinatal periods of exposure to specific outcomes. The present results with our clinically relevant animal model of repeated, brief, high-concentration binge prenatal toluene exposure demonstrate the dose-dependent effect of toluene on prenatal development, early postnatal maturation, spontaneous exploration, and amphetamine-induced locomotor activity. The results imply that abuse patterns of toluene exposure may be more deleterious than typical occupational exposure on fetal development and suggest that animal models are effective in studying the mechanisms and risk factors of organic solvent teratogenicity.

Authors and Affiliations

Scott E. Bowen, John H. Hannigan

Keywords

Related Articles

Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions

Indolealkylamine (IAA) drugs are 5-hydroxytryptamine (5-HT or serotonin) analogs that mainly act on the serotonin system. Some IAAs are clinically utilized for antimigraine therapy, whereas other substances are notable a...

Pharmacodynamic Modeling of Sequence-Dependent Antitumor Activity of Insulin-like Growth Factor Blockade and Gemcitabine

The online version of this article (doi:10.1208/s12248-011-9308-3) contains supplementary material, which is available to authorized users.

Screening of Bioactive Peptides Using an Embryonic Stem Cell-Based Neurodifferentiation Assay

Differentiation of pluripotent stem cells, PSCs, towards neural lineages has attracted significant attention, given the potential use of such cells for in vitro studies and for regenerative medicine. The present experime...

Role of MRP4 and MRP5 in biology and chemotherapy

Nucleotide efflux (especially cyclic nucleotides) from a variety of mammalian tissues, bacteria, and lower eukaryotes has been studied for several decades. However, the molecular identity of these nucleotide efflux trans...

Simplification of Complex Physiologically Based Pharmacokinetic Models of Monoclonal Antibodies

The online version of this article (doi:10.1208/s12248-014-9591-x) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP681796
  • DOI  10.1007/BF02854915
  • Views 106
  • Downloads 0

How To Cite

Scott E. Bowen, John H. Hannigan (2006). Developmental toxicity of prenatal exposure to toluene. The AAPS Journal, 8(2), -. https://europub.co.uk./articles/-A-681796